This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Roberto Lipsztein, MD; Jack F. Dalton, MD; William D. Bloomer, MD

JAMA. 1985;253(24):3582-3584.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IONIZING radiation is one of many mutagenic and carcinogenic agents encountered in the environment. The fact that radiotherapy and chemotherapy can both cause and cure cancer is a fascinating paradox of modern therapeutics and one that must be constantly considered when evaluating the risks and benefits of cancer therapy. Because absolute safety is rarely a reasonable goal, the physician's responsibility is to determine tolerable levels of risk.

Lumpectomy and radiotherapy are becoming an increasingly accepted alternative to the traditional modified radical mastectomy for the treatment of breast cancer. The results to date, both in terms of overall survival and cosmetic appearance, are encouraging.¹ Radiation treatments are facilitated and normal tissue tolerance preserved by resection of gross tumor mass. Breast reconstruction permits the resection of lesions up to 4 cm in size without marked cosmetic deformity.

All therapeutic decisions involve risks and benefits. The clinical spectrum of the effects of . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Radiotherapy, The Mount Sinai Medical Center, New York.

Footnotes
Reprint requests to Department of Radiotherapy, The Mount Sinai Medical Center, 1 Gustave L. Levy PI, New York, NY 10029 (Dr Bloomer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?